Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHZD.L Regulatory News (HZD)

  • There is currently no data for HZD

Director/PDMR Shareholding

26 Jun 2020 07:00

RNS Number : 1493R
Horizon Discovery Group plc
26 June 2020
 

Horizon Discovery Group plc

26 June 2020

 

 

Horizon Discovery Group plc

Director/PDMR Shareholding

Cambridge, UK, 26 June 2020: Horizon Discovery Group plc (LSE: HZD) ("Horizon", "the Group" or "the Company"), a cell engineering company focused on commercialising the application of gene editing and gene modulation to accelerate scientific innovation and biopharmaceutical drug development, today announces that on 25 June 2020 certain of the Directors purchased ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares").

Details of these purchases of Ordinary Shares, and each Director's resulting beneficial interest in the Company's issued share capital, are shown below:

Name of Director

Number of Ordinary Shares purchased

Purchase price per share (pence)

Resulting number of Ordinary Shares held

Resulting number of Ordinary Shares held as a percentage of the Company's issued share capital

Ian Gilham

25,000

99.99p

140,037

0.09%

Susan Searle*

10,000

5,309

101.10p

101.06p

90,000

0.06%

 

*10,000 Ordinary Shares were purchased for her ISA and 5,309 Ordinary Shares for her spouse's ISA.

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Ian Gilham

2

Reason for the notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Horizon Discovery Group plc

b)

Legal Entity Identifier

213800L812B9NI5M3G89

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 Identification code

Ordinary shares of 1.0 pence each

 GB00BK8FL363

b)

Nature of the transaction

Purchase of shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price

No. of shares

£0.999

25,000

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

25,000

£0.999

£24,997.50

f)

Date of the transaction

25 June 2020

g)

Place of the transaction

London Stock Exchange, AIM

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Susan Searle

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Horizon Discovery Group plc

b)

Legal Entity Identifier

213800L812B9NI5M3G89

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 Identification code

Ordinary shares of 1.0 pence each

 GB00BK8FL363

b)

Nature of the transaction

Purchase of shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price

No. of shares

£1.011

10,000

£1.011

5,309

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

15,309

£1.011

£15,477.40

f)

Date of the transaction

25 June 2020

g)

Place of the transaction

London Stock Exchange, AIM

 

- ENDS -

For further information from Horizon Discovery Group plc, please contact:

 

Horizon Discovery Group plc

Terry Pizzie, Chief Executive Officer

Jayesh Pankhania, Chief Financial Officer

Jon Davies, Head of Investor Relations

Tel: +44 (0) 1223 655 580

 

Numis Securities Limited (Broker and NOMAD)

Freddie Barnfield / Duncan Monteith / Oliver Steele

Tel: +44 (0) 207 260 1000

 

Consilium Strategic Communications (Financial Media and UK Investor Relations)

Mary-Jane Elliott / Matthew Neal / Melissa Gardiner

Tel: +44 (0) 20 3709 5700

Email: horizon@consilium-comms.com

 

Westwicke, an ICR Company (US Investor Relations)

Stephanie Carrington

Tel. +1 646-277-1282

Email: horizondiscovery@icrinc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDGGDLUBDDGGU
Date   Source Headline
24th Jul 20197:00 amRNSTrading Update
8th Jul 20197:00 amRNSSMARTvector platform supports Celyad IND filing
5th Jul 20198:01 amRNSDirector/PDMR Shareholding
3rd Jul 201912:07 pmRNSSecond Price Monitoring Extn
3rd Jul 201912:02 pmRNSPrice Monitoring Extension
1st Jul 20194:29 pmRNSHolding(s) in Company
25th Jun 20197:00 amRNSDirector/PDMR Shareholding
19th Jun 20196:28 pmRNSHolding(s) in Company
19th Jun 20196:17 pmRNSHolding(s) in Company
18th Jun 20191:16 pmRNSResult of AGM
7th Jun 20191:17 pmRNSTotal Voting Rights
21st May 201912:05 pmRNSAnnual Report and Notice of Annual General Meeting
29th Apr 20197:00 amRNSFull Year Results for Year Ending 31 December 2018
25th Apr 20197:00 amRNSHoldings in Company
1st Apr 201912:33 pmRNSDirector/PDMR Shareholding
20th Mar 20197:00 amRNSNotice of Full Year Results
15th Mar 20195:44 pmRNSDirector/PDMR Shareholding
11th Mar 20197:00 amRNSPresentation at 2019 Cowen Health Care Conference
1st Mar 20195:46 pmRNSTotal Voting Rights
7th Feb 201912:22 pmRNSDirector/PDMR Shareholding
5th Feb 20197:00 amRNSHoldings in Company
4th Feb 201911:08 amRNSHoldings in Company
1st Feb 20192:56 pmRNSTotal Voting Rights
29th Jan 20197:00 amRNSAppointment of Chief Financial Officer
29th Jan 20197:00 amRNSPre-Close Trading Update
28th Jan 201912:08 pmRNSBlock listing Interim Review
28th Jan 20197:00 amRNSPartnership with Rutgers for new technology
21st Jan 20194:35 pmRNSPrice Monitoring Extension
18th Dec 201812:07 pmRNSSecond Price Monitoring Extn
18th Dec 201812:02 pmRNSPrice Monitoring Extension
17th Dec 20187:00 amRNSExclusive Partnership with C4X Discovery
10th Dec 201812:17 pmRNSTotal Voting Rights
12th Nov 201810:33 amRNSGrant of options
12th Nov 20189:00 amRNSHolding(s) in Company
12th Nov 20187:00 amRNSTotal Voting Rights
8th Nov 20187:00 amRNSBoard Change
7th Nov 20187:00 amRNSCRISPR Screening Webinar
18th Oct 20187:00 amRNSCRISPR Screening Webinar
17th Oct 20187:00 amRNSHoldings in Company
16th Oct 20183:29 pmRNSHolding(s) in Company
15th Oct 201810:16 amRNSHolding(s) in Company
9th Oct 201812:32 pmRNSTotal Voting Rights
18th Sep 20185:56 pmRNSHolding(s) in Company
18th Sep 20185:49 pmRNSTotal Voting Rights
17th Sep 20187:00 amRNSInterim Results for Six Months Ended 30 June 2018
4th Sep 20187:00 amRNSHoldings in Company
3rd Aug 20187:00 amRNSPre-Close Trading Update
26th Jul 20189:01 amRNSBlock Listing Six Monthly Return
6th Jul 20185:49 pmRNSTotal Voting Rights
21st Jun 20184:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.